Trial Profile
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ixmyelocel-T (Primary)
- Indications Alveolar bone loss
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2014 New trial record